Table 1.

Reconstitution analysis in lethally irradiated mice transplanted with cultured hematopoietic stem cells on ALCAM-transfected stromal cells

Primary fetal liver stem cellsCultured cellsTotal % Ly5.1 cells with
vector-transfected cells
Total % Ly5.1 cells with
ALCAM-transfected cells (GM2)
7 days25 days7 days25 days
10.1% ± 5.8% (500 cells/mouse) One sixth of culture ND 0.7% ± 0.2% ND 3.2% ± 2.1% 
18.2% ± 14.3% (1000 cells/mouse) One third of culture 1.5% ± 1.2% 0.9% ± 0.2% 9.4% ± 4.4% 6.2% ± 0.9% 
Primary fetal liver stem cellsCultured cellsTotal % Ly5.1 cells with
vector-transfected cells
Total % Ly5.1 cells with
ALCAM-transfected cells (GM2)
7 days25 days7 days25 days
10.1% ± 5.8% (500 cells/mouse) One sixth of culture ND 0.7% ± 0.2% ND 3.2% ± 2.1% 
18.2% ± 14.3% (1000 cells/mouse) One third of culture 1.5% ± 1.2% 0.9% ± 0.2% 9.4% ± 4.4% 6.2% ± 0.9% 

Day 14 fetal liver cells (Ly5.1) were purified for LinSca-1+c-Kit+ cells, and 3000 stem cells were cultured with ALCAM- or vector-transfected cell lines for 7 days or 25 days. Cells were harvested, and one third of culture (corresponding to 1000 stem cells) or one sixth of culture (corresponding to 500 stem cells) was transplanted with 1 × 106 Ly5.2 competitor bone marrow cells into lethally irradiated Ly5.2 mice. The expression of the donor-type Ly5.1 marker on peripheral blood cells was examined 12 weeks after transplantation. Three independent experiments were performed, and representative data were obtained from one experiment.

ND indicates not done.

Close Modal

or Create an Account

Close Modal
Close Modal